These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 29753086)

  • 1. Applications of proteomics in pharmaceutical research and development.
    Yokota H
    Biochim Biophys Acta Proteins Proteom; 2019 Jan; 1867(1):17-21. PubMed ID: 29753086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoproteomic approaches to drug target identification and drug profiling.
    Bantscheff M; Drewes G
    Bioorg Med Chem; 2012 Mar; 20(6):1973-8. PubMed ID: 22130419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in omics for informed pharmaceutical research and development in the era of systems medicine.
    Bai JPF; Melas IN; Hur J; Guo E
    Expert Opin Drug Discov; 2018 Jan; 13(1):1-4. PubMed ID: 29073782
    [No Abstract]   [Full Text] [Related]  

  • 4. Proteomics in Pharmaceutical Research and Development.
    Cutler P; Voshol H
    Proteomics Clin Appl; 2015 Aug; 9(7-8):641-2. PubMed ID: 26178466
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent advancements in differential proteomics based on stable isotope coding.
    Julka S; Regnier FE
    Brief Funct Genomic Proteomic; 2005 Jul; 4(2):158-77. PubMed ID: 16102271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Frontier Pharmaceutics to Be Explored by Young Scientists: DDS Research for Innovative Drug Development].
    Asai T; Tachikawa M
    Yakugaku Zasshi; 2016; 136(1):37-8. PubMed ID: 26725665
    [No Abstract]   [Full Text] [Related]  

  • 7. Artificial intelligence in drug discovery and development.
    Paul D; Sanap G; Shenoy S; Kalyane D; Kalia K; Tekade RK
    Drug Discov Today; 2021 Jan; 26(1):80-93. PubMed ID: 33099022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional proteomics: mapping protein-protein interactions and pathways.
    Figeys D
    Curr Opin Mol Ther; 2002 Jun; 4(3):210-5. PubMed ID: 12139305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Discovery of drug targets by quantitative proteomics and their clinical application].
    Tomonaga T
    Nihon Yakurigaku Zasshi; 2017; 149(3):123-127. PubMed ID: 28260742
    [No Abstract]   [Full Text] [Related]  

  • 10. Proteomics in pharmaceutical research and development.
    Cutler P; Voshol H
    Proteomics Clin Appl; 2015 Aug; 9(7-8):643-50. PubMed ID: 25763573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of LC/MS to proteomics studies: current status and future prospects.
    Chen G; Pramanik BN
    Drug Discov Today; 2009 May; 14(9-10):465-71. PubMed ID: 19429505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-dimensional gels for toxicological drug discovery applications.
    Witzmann FA; Richardson MR
    Expert Opin Drug Metab Toxicol; 2006 Feb; 2(1):103-11. PubMed ID: 16863472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity- and reactivity-based proteomics: Recent technological advances and applications in drug discovery.
    Benns HJ; Wincott CJ; Tate EW; Child MA
    Curr Opin Chem Biol; 2021 Feb; 60():20-29. PubMed ID: 32768892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Artificial Intelligence Approach to Proactively Inspire Drug Discovery with Recommendations.
    Rohall SL; Auch L; Gable J; Gora J; Jansen J; Lu Y; Martin E; Pancost-Heidebrecht M; Shirley B; Stiefl N; Lindvall M
    J Med Chem; 2020 Aug; 63(16):8824-8834. PubMed ID: 32101427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artificial intelligence in pharmaceutical research and development.
    Mitchell JB
    Future Med Chem; 2018 Jul; 10(13):1529-1531. PubMed ID: 29966438
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacoproteomic approach by quantitative targeted proteomics].
    Ohtsuki S
    Yakugaku Zasshi; 2012; 132(4):479-87. PubMed ID: 22465926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating transcriptome and proteome profiling: Strategies and applications.
    Kumar D; Bansal G; Narang A; Basak T; Abbas T; Dash D
    Proteomics; 2016 Oct; 16(19):2533-2544. PubMed ID: 27343053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics approaches for myeloid leukemia drug discovery.
    Kapoor I; Pal P; Lochab S; Kanaujiya JK; Trivedi AK
    Expert Opin Drug Discov; 2012 Dec; 7(12):1165-75. PubMed ID: 22971110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemical proteomics and discovery of drug targets].
    Yang HQ; Li XJ
    Yao Xue Xue Bao; 2011 Aug; 46(8):877-82. PubMed ID: 22007509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innovations driving biomarker evaluation and use.
    Wagner JA
    Biomark Med; 2010 Dec; 4(6):779-81. PubMed ID: 21133694
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.